Orange County Business Journal

Edwards Rises on 2013 Sapien Forecast

Vita Reed Tuesday, December 4, 2012

Shares of Irvine heart valve maker Edwards Lifesciences Corp. rose today after it said it expects strong sales for its less-invasive heart valves next year.

Edwards’ shares rose nearly 6% to a market value of $10.6 billion.

The company said at an investor conference that it expects 2013 sales of its less-invasive Edwards Sapien heart valve line to come in at $710 million to $790 million, up from its 2012 projection of $560 million to $630 million.

Transcatheter heart valves have accounted for $391.1 million in sales through the first nine months of 2012 for Edwards.